StonvexLoading…
StonvexStonvexStonvexCore line items from ADAG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.67M | $103.20K | $18.11M | $9.29M |
Operating Income | $-21.44M | $-35.95M | $-23.72M | $-83.92M |
Net Income | $-17.61M | $-33.42M | $-18.95M | $-79.97M |
EPS (Diluted) | $-0.30 | $-0.59 | $-0.35 | $-1.48 |
Total Assets | $78.26M | $89.27M | $115.73M | $152.40M |
Total Liabilities | $26.36M | $38.74M | $45.17M | $69.31M |
Cash & Equivalents | $74.52M | $85.19M | $109.93M | $143.76M |
Free Cash Flow OCF − CapEx | $-15.67M | $-29.73M | $-28.54M | $-49.30M |
Shares Outstanding | 59.23M | 58.89M | 55.15M | 54.07M |